Wednesday, July 8, 2026

Patent intelligence · US

US 10888529

Vehicles for the transfection of miRNAs

granted A61KA61K31/7105A61K47/186A61K9/5123
Status granted
Linked drugs 3
Pipeline programs 6
Years to expiry 15
Applicant portfolio 35
Patent details — US 10888529

Quick answer

US 10888529 (Vehicles for the transfection of miRNAs) is held by UNIVERSIDAD DEL PAÍS VASCO / EUSKAL HERRIKO UNIBERTSITATEA. Status: granted. Granted Jan 12, 2021. Expires Jan 7, 2041 (15 years remaining) — relevant for patent-cliff and LOE planning.

Key facts

Grant date
Expiration
Claims
17
CPC classes
A61K, A61K31/7105, A61K47/186, A61K9/5123, A61P, A61P11/00

More from UNIVERSIDAD DEL PAÍS VASCO / EUSKAL HERRIKO UNIBERTSITATEA

Related pharmaceutical patents in our USPTO index.

  1. US 12226429

    Highly active compounds against COVID-19

    Atea Pharmaceuticals, Inc. · Expires Feb 13, 2045

    granted
  2. US 12084473

    β-D-2′-deoxy-2′-α-fluoro-2′-β-C-substituted-2-modified-N6-substituted purine nucleotides for HCV treatment

    Atea Pharmaceuticals, Inc. · Expires Sep 5, 2044

    granted
  3. US 12006340

    Nucleotide hemi-sulfate salt for the treatment of hepatitis c virus

    Atea Pharmaceuticals, Inc. · Expires Jun 6, 2044

    granted
  4. US 12005139

    Ophthalmic formulations and related methods

    ETERNATEAR, INC. · Expires Jun 6, 2044

    granted
  5. US 11975016

    2′-substituted-N6-substituted purine nucleotides for RNA virus treatment

    Atea Pharmaceuticals, Inc. · Expires May 2, 2044

    granted
  6. US 11964047

    Ophthalmic formulations and related methods

    ETERNATEAR, INC. · Expires Apr 18, 2044

    granted
  7. US 11833160

    Ursodeoxycholic acid derivatives as HDAC inhibitors for the treatment of polycystic diseases

    UNIVERSIDAD DEL PAÍS VASCO / EUSKAL HERRIKO UNIBERTSITATEA · Expires Nov 30, 2043

    granted
  8. US 11813278

    Highly active compounds against COVID-19

    Atea Pharmaceuticals, Inc. · Expires Nov 9, 2043

    granted

Frequently asked questions

What is US patent 10888529?

US 10888529 (Vehicles for the transfection of miRNAs) is held by UNIVERSIDAD DEL PAÍS VASCO / EUSKAL HERRIKO UNIBERTSITATEA. Status: granted. Granted Jan 12, 2021. Expires Jan 7, 2041 (15 years remaining) — relevant for patent-cliff and LOE planning.

Who owns US 10888529?

UNIVERSIDAD DEL PAÍS VASCO / EUSKAL HERRIKO UNIBERTSITATEA is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 35 pharmaceutical patents for this assignee.

When does US 10888529 expire?

Our index shows an expiration date of Jan 7, 2041 (15 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.